statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kazia Therapeutics Limited (NASDAQ:KZIA  Get Free Report) was the target of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling...

Kazia Therapeutics Limited (NASDAQ:KZIA) Short Interest Update

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Kazia Therapeutics licenses paxalisib to Sovargen

Kazia announces presentation of new data at AACR Annual Meeting Kazia announces presentation of new data at AACR Annual Meeting PR Newswire SYDNEY, March 13, 2024 SYDNEY, March 13, 2024 /PRNewswire...

Kazia announces presentation of new data at AACR Annual Meeting

Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint PR Newswire...

Kazia Therapeutics Reports Early Conclusion of Clinical Trial After Reaching Primary Endpoint

Kazia Therapeutics files to sell 4.76M ADSs for holders

KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS PR Newswire SYDNEY, Jan. 18, 2024 SYDNEY, Jan. 18, 2024 /PRNewswire/ -- Kazia...

KAZIA CONTINUES BOARD RENEWAL WITH TWO NEW APPOINTMENTS

Kazia Therapeutics Ltd. is a clinical stage oncology company, which engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

Volume	55,572.00
52-Wk High	$1.39
52-Wk Low	$0.1866

KZIA Kazia Therapeutics

About

Feed

News

Fundamentals